Research Article

THE PREVALENCE OF HEPATITIS B AND C VIRUS INFECTIONS IN TYPE 2 DIABETES MELLITUS
  • Vahap OKAN
  • Mustafa ARAZ
  • Fikret DEMIRCI
  • Tekin KARSLIGIL
  • Ahmet SEZER
  • Hasan MICOZKADIOGLU
  • Sebnem AKTARAN
  • Yalçin KEPEKÇI
Viral Hepat J 2000; 6: 0-0
Hepatitis B and C Sero-prevalence in Patients with Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome at a Tertiary Care Hospital in Izmir
  • Sabri ATALAY
  • Tuba TATLI KIŞ
  • Ufuk SÖNMEZ
  • Şükran KÖSE
Viral Hepat J 2018; 24: 3-6 DOI: 10.4274/vhd.0005
Long-term Sustained Virological Response Rate in Treatment of Chronic Hepatitis C Patients
  • Mustafa SÜNBÜL
  • Tuba KURUOĞLU
  • İsmail Hakkı DÜNDAR
  • Şaban ESEN
  • Cafer EROĞLU
  • Hakan LEBLEBİCİOĞLU
Viral Hepat J 2008; 13: 7-11
Seroprevalence of Hepatitis B Surface Antigen, Anti-Hepatitis B Surface and Anti-Hepatitis C Virus Among Pregnant Women Residing in Şırnak Province
  • Meyha ŞAHİN
  • Meltem ZENCİR
  • Alper Akın GÖZÜBÜYÜK
  • Bedri Aras PEKTAŞ
Viral Hepat J 2018; 24: 7-11 DOI: 10.4274/vhd.0010
Seroprevalence of Hepatitis B, Hepatitis C, HIV and Syphilis in Blood Donors in Tokat
  • Nermin BULUT
  • Gülgün YENISEHIRLI
  • Yunus BULUT
Viral Hepat J 2012; 18: 11-14 DOI: 10.4274/Vhd.18.03
Seroprevalences of Hepatitis B, Hepatitis C, HIV of the Healthcare Workers in the Gaziantep University Sahinbey Research and Training Hospital
  • Vuslat KEÇİK BOŞNAK
  • İlkay KARAOĞLAN
  • Mustafa NAMIDURU
  • Ahmet ŞAHİN
Viral Hepat J 2013; 19: 11-14 DOI: 10.4274/Vhd.69188
The Evaluation of Mean Platelet Volume in Hepatitis C Infection
  • Fatih DEMİRCAN
  • Faruk KILINÇ
  • Nevzat GÖZEL
  • Banu ERKALMA ŞENATEŞ
  • Ebubekir ŞENATEŞ
Viral Hepat J 2014; 20: 11-14 DOI: 10.4274/Vhd.65365
A Comparison of Interferon a-2a Plus Ribavirin Combination Therapy with Peginterferon a-2a Plus Ribavirin Combination Therapy for the Treatment of Chronic Hepatitis C
  • Hayati DEMIRASLAN
  • Bilgehan AYGEN
  • Orhan YILDIZ
  • Işın SOYUER
  • Selma GÖKAHMETOĞLU
Viral Hepat J 2008; 13: 12-22
Perinatal Transmission of Hepatitis B Virus despite the Active and Passive Immunoprophylaxis: A Case Report
  • Ayfer GÖRAL
  • Özgür GÜNAL
Viral Hepat J 2011; 17: 12-15
Seven-year Genotype Distribution Among Hepatitis C Patients in a City in the Central Anatolia Region of Turkey
  • Uğur TÜZÜNER
  • Begüm SARAN GÜLCEN
  • Mehmet ÖZDEMİR
  • Bahadır FEYZİOĞLU
  • Mahmut BAYKAN
Viral Hepat J 2018; 24: 12-17 DOI: 10.4274/vhd.0013
Investigation of Hepatitis Serology and Occupational Exposure Risk to Viral Hepatitis in Hospital Housekeeping Staff
  • Semiha SOLAK GRASSIE
  • Sümeyra ÇETİN GEVREK
Viral Hepat J 2016; 22: 14-17 DOI: 10.4274/vhd.27147
IFN-a2b Induction Treatment with Ribavirin in Patients with Chronic Hepatitis C
  • Yunus GÜRBÜZ
  • Ediz TÜTÜNCÜ
  • Ruçhan TÜRKYILMAZ
Viral Hepat J 2005; 10: 15-18
Hepatitis B and Hepatitis C Seropositivities in Women Admitted To Gynecology and Obstetrics Hospital in Sanliurfa City: A 3- Year Evaluation
  • Aysegül ÇOPUR ÇIÇEK
  • Ibrahim Halil INAKÇI
  • Fazilet DUYGU
Viral Hepat J 2012; 18: 15-18 DOI: 10.4274/Vhd.18.04
Changing Epidemiology of Chronic Hepatitis C in Adana
  • Ferit KUŞCU
  • Süheyla KÖMÜR
  • Ayşe Seza İNAL
  • Aslıhan Candevir ULU
  • Behice KURTARAN
  • Yeşim TAŞOVA
  • Berrin ÜNLÜ
  • Dürdane MIDIKLI
  • Zehra Dogan TOMUL
  • Gürkan YILMAZ
  • Bedia Mutay SUNTUR
  • Hasan Salih Zeki AKSU
Viral Hepat J 2014; 20: 15-18 DOI: 10.4274/Vhd.70299
The Efficiency of Hepatitis C Virus Core Antigen Test in the Diagnosis of Hepatitis C Infection
  • Mehmet Emin DEMİRCİLİ
  • Mehmet ÖZDEMİR
  • Bahadır FEYZİOĞLU
  • Bülent BAYSAL
Viral Hepat J 2016; 22: 18-22 DOI: 10.4274/vhd.78300
Should Hepatitis C Virus Antibody Be Used for Screening Purposes?
  • Birol ŞAFAK
  • Özge TOMBAK
  • Aynur EREN TOPKAYA
Viral Hepat J 2018; 24: 18-20 DOI: 10.4274/vhd.0018
Seroprevalance of Hepatitis B Virus, Hepatitis C Virus and Hepatitis D Virus in Healthy Blood Donors
  • Fatma SIRMATEL
  • Gülay YETKIN
  • Fatma Nur ERIS
  • Süda TEKIN KORUK
  • Fazilet DUYGU
  • Leman KARAAGAÇ
  • Sevim DINÇER
Viral Hepat J 2012; 18: 19-22 DOI: 10.4274/Vhd.18.05
Seroprevalance of Hepatitis B, Hepatitis C, Human Immunodeficiency Virus and Syphilis Infections in Blood Donors
  • Gül KARAGÖZ
  • Ayten KADANALI
  • Mehmet Fatih BEKTASOGLU
  • Behiye DEDE
  • Sevda BABACAN ALTUG
Viral Hepat J 2012; 18: 26-28 DOI: 10.4274/Vhd.18.07
Seroprevalences of Hepatitis B and C in Patients undergoing an Operation
  • Filiz PEHLIVANOGLU
  • Kadriye KART YASAR
  • Gönül SENGÖZ
Viral Hepat J 2011; 17: 27-31
Hepatitis C Virus Genotyping by Using Restriction Fragment Length Polymorphism (RFLP) in Anti-HCV Positive Hemodialysis Patients and Renal Transplant Recipients
Viral Hepat J 2005; 10: 28-33
Correlation Between Hepatitis B and C Positivity and Rheumatoid Factor Levels in Patients with Rheumatoid Arthritis
  • Songül ÇILDAĞ
  • Taşkın ŞENTÜRK
Viral Hepat J 2014; 20: 28-31 DOI: 10.4274/Vhd.97269
The Relationship Between the Serum RNA Titers of Hepatitis C Virus and Biochemical Parameters in Chronic Hepatitis C Patients
  • Rukiye NAR
  • Fikriye MİLLETLİ SEZGİN
Viral Hepat J 2016; 22: 28-33 DOI: 10.4274/vhd.24008
Lichenoid Drug Reaction Developing During the Treatment of Recurrent Chronic Hepatitis C
  • Çiğdem KADER
  • Emine ÇÖLGEÇEN ÖZEL
  • Selda SEÇKİN
  • Ayşe ERBAY
Viral Hepat J 2014; 20: 32-35 DOI: 10.4274/Vhd.04706
ß2-Microglobulin Levels in Hepatitis C Virus Infection
  • Tamer SANLIDAG
  • Sinem AKÇALI
  • Ismail TOSUN
  • Beril ÖZBAKKALOGLU
Viral Hepat J 2005; 10: 37-40
TNF-alpha 308 SNP Rs3091256 GG Genotype is Strongly Associated with Fibrosis in Patients with Chronic Hepatitis C
  • Özgür GÜNAL
  • Didem YALÇIN
  • Betül ÇELİK
  • Aydın RÜSTEMOĞLU
  • Osman DEMİR
  • Şener BARUT
  • Ömer ATEŞ
  • Sırrı KILIÇ
Viral Hepat J 2017; 23: 39-45 DOI: 10.4274/vhd.93723
Hepatitis C Prevalence in Different Age Groups; People Over 50 Years of Age May Receive One-Time Testing for Anti-HCV
  • Özlem AYDEMİR
  • Tayfur DEMİRAY
  • Mehmet KÖROĞLU
  • İhsan Hakkı ÇİFTÇİ
  • Ahmet ÖZBEK
  • Mustafa ALTINDİŞ
Viral Hepat J 2015; 21: 40-43 DOI: 10.4274/vhd.35220
Effect of Chronic Hepatitis B and C Infections on Prolactin and Pituitary-Thyroid Axis
  • Hamza Murat AKIN
  • M. Ali EREN
  • Tevfik SABUNCU
  • Süda TEKIN KORUK
Viral Hepat J 2011; 17: 47-51
The Frequency of Hepatitis B Virus, Hepatitis C Virus and Human Immunodeficiency Virus Infections among Patients with Schizophrenia in a Mental Health Hospital in Turkey
  • Nuran KARABULUT
Viral Hepat J 2016; 22: 48-51 DOI: 10.4274/vhd.38981
Investigation of Hepatitis-B and C Seroprevelances in Bozok University School of Health Students
  • Çiğdem KADER
  • Sadiye YOLCU
  • Ayşe ERBAY
  • Nazan KILIÇ AKÇA
  • Selda YÜZER
  • Sevinç POLAT
Viral Hepat J 2013; 19: 49-53 DOI: 10.4274/Vhd.70288
Does Vitamin D Level Affect the Response to Antiviral Treatment in Egyptian Patients with Chronic Hepatitis C?
  • Hoda Abdelbadie HUSSEIN
  • Hany Badreldin MOHAMAD
  • Mohamad Abdelhadi MASHAHEET
  • Maher Abubakr ALAMIR
  • Ghada Mohamad EZZAT
Viral Hepat J 2017; 23: 50-54 DOI: 10.4274/vhd.73745
Seroprevalence of Hepatitis B and Hepatitis C in Patients with HIV/AIDS
  • Hayat KUMBASAR KARAOSMANOGLU
  • Özlem ALTUNTAS AYDIN
  • Emine Rahsan INCE
  • Özcan NAZLICAN
Viral Hepat J 2009; 14: 53-56
Seropositivity of Hepatitis B and Hepatitis C in women who were admitted to Hatay Maternityand Children's Hospital
  • Vicdan KÖKSALDI MOTOR
  • Ömer EVIRGEN
  • Mehmet AKSAKAL
  • Melek INCI
  • Yusuf ÖNLEM
  • Sabahattin OCAK
Viral Hepat J 2010; 16: 53-56
The Evaluation of the Seroprevalence of HBV and HCV Infections in Patients with Hemodialysisin Hatay City and the Assessment of Antibody Response to Hepatitis B Vaccination
  • Ömer EVIRGEN
  • Yusuf ÖNLEN
  • Vicdan KÖKSALDI MOTOR
  • Erkan MAHSERECI
  • Melek INCI
  • Sule SAHIN
Viral Hepat J 2010; 16: 57-63
Telaprevir-based Triple Therapy for Retreatment of Chronic Hepatitis C Patients with Genotype Four Followed in Our Clinic
  • Zehra BEŞTEPE DURSUN
  • İlhami ÇELİK
Viral Hepat J 2016; 22: 58-61 DOI: 10.4274/vhd.94695
The Effectivity of Combination of Standard Interferon-a + Ribavirin and Pegylated Interferon-a + Ribavirin Therapy in Patients with Chronic Hepatitis C
  • Nail ÖZGÜNES
  • Fatma SARGIN
  • Saadet YAZICI
  • Nüket CEYLAN
  • Ayse Canan ÜÇISIK
  • Pinar ERGEN
  • Arzu DOGRU
  • Özlem AYDIN
Viral Hepat J 2006; 11: 61-64
Evaluation of Hepatitis C Patients in Şanlıurfa Region
  • Haşim NAR
  • Ahmet UYANIKOĞLU
  • Timuçin AYDOĞAN
  • Necati YENİCE
Viral Hepat J 2013; 19: 62-66 DOI: 10.4274/Vhd.74429
Seroprevalence of Hepatitis B and Hepatitis C of Children living in Izmir Social Services andChild Protection Institution
Viral Hepat J 2010; 16: 64-68
Screening Indicators of Hepatitis A, Hepatitis B, Hepatitis C and HIV infections in Prisoners
  • Elçin BALCI
  • Kamuran TÜRKER
  • Vesile SENOL
  • Osman GÜNEY
Viral Hepat J 2012; 18: 64-67 DOI: 10.4274/Vhd.32932
The Frequency of HBV and HCV in Pregnant Women in Rural Areas
  • Ibak GÖNEN
Viral Hepat J 2011; 17: 66-68
The Relationship Between Distribution of HCV-RNA and ALT-AST Levels with Genotypes of Hepatitis C Virus Infected Patients
  • Özlem KİRİŞÇİ
  • Ahmet ÇALIŞKAN
  • Sümeyra ALKIŞ KOÇTÜRK
  • Pınar ERDOĞMUS
  • Mustafa GÜL
Viral Hepat J 2013; 19: 67-70 DOI: 10.4274/Vhd.57966
Diagnosis of Hepatitis C Infection in Turkey: How Can Serology be Helpful?
  • Kemal Osman MEMIKOGLU
  • Hakan ARABACI
  • Alpay AZAP
  • Aysegül YESILKAYA
  • Serhat BIRENGEL
  • Ismail BALIK
Viral Hepat J 2007; 12: 68-72
Evaluation of 219 Patients with Chronic Hepatitis C Receiving Pegylated Interferon + Ribavirin Treatment
  • Nevil AYKIN
  • Figen ÇAĞLAN ÇEVİK
  • Hasan NAZ
  • Pınar KORKMAZ
  • Tercan US
Viral Hepat J 2013; 19: 71-75 DOI: 10.4274/Vhd.77486
Hepatitis C Prevalence and Responses to Pegylated Interferon + Ribavirin Treatment Among Prisoners
  • Hasan Selçuk ÖZGER
  • Ömer KARAŞAHİN
  • Mehmet Armağan TOY
  • Sibel İBA YILMAZ
  • Kenan HIZEL
Viral Hepat J 2017; 23: 71-75 DOI: 10.4274/vhd.0007
The Frequency of Hepatitis B and Hepatitis C in Primary Health Care Centers from Rural and Urban Areas of Mersin Province
  • Özlem KANDEMIR
  • Öner KURT
Viral Hepat J 2011; 17: 74-83
The Prevalence of HBsAg, Anti HCV and Anti HIV Before Upper Gastrointestinal Endoscopy
  • Sami CIFCI
  • Murat BIYIK
  • Mehmet ASIL
  • Serhat SAYIN
  • Hüseyin ATASEVEN
  • Ali DEMIR
Viral Hepat J 2014; 20: 78-80 DOI: 10.4274/vhd.96168
Evaluation of Sustained Virological Response in Patients with Genotype 1b Chronic Hepatitis C Infection
  • Esragül AKINCI
  • Bircan ÜNAL KAYAASLAN
  • Aliye TANRICI BAŞBUĞ
  • Selim Sırrı EREN
  • Pınar ÖNGÜRÜ
  • Hürrem BODUR
Viral Hepat J 2013; 19: 80-84 DOI: 10.4274/Vhd.68077
Skin Disease after Chronic Hepatitis C: Two Cases Report
  • Yunus GÜRBÜZ
  • Emin Ediz TÜTÜNCÜ
  • Dogan Baris ÖZTÜRK
  • Ayse BAYLAK
  • Irfan SENCAN
Viral Hepat J 2011; 17: 84-87
Comparison of the Efficacy of Standard Interferon Alpha 2a Plus Ribavirin and PegylatedInterferon Alpha 2a Plus Ribavirin Combination Therapies in the Treatment of ChronicHepatitis C Infection
  • Sua SÜMER
  • Onur URAL
  • Nazlim AKTUGDEMIR
  • Gaye URAL
  • Mehmet BALCI
  • Nebahat DIKICI
Viral Hepat J 2009; 14: 89-90
Evaluation of Non-invasive Methods for Prediction of Fibrosis in Chronic Hepatitis B and CInfections
  • Onur KAYA
  • Füsun Zeynep AKÇAM
  • Yonca SÖNMEZ
  • Arzu TIGLI
  • Metin ÇIRIS
Viral Hepat J 2009; 14: 91-97
Distribution of HCV Genotypes in Patients of with Chronic Hepatitis C in the Eastern Anatolia Region
  • Osman Aktaş
  • Ahmet Özbek
  • Hakan Aydın
  • Mehmet Beyhan Özkülekçi
Viral Hepat J 2014; 20: 91-94 DOI: 10.4274/vhd.41736
Investigation of Hepatitis A, B and C Serology Among Civil Defense Workers and Comparison with the Normal Population
  • Semiha SOLAK GRASSIE
  • Fatih OCAK
  • Bircan KAYAASLAN
Viral Hepat J 2015; 21: 94-97 DOI: 10.4274/vhd.73644
Waiting for Interferon-free Regimens for Chronic Hepatitis C Patients: A Multicenter Observational Study
  • Rahmet Güner
  • Zeliha Koçak Tufan
  • Cemal Bulut
  • Gülden Ersöz
  • Ayşe Batırel
  • Bahar Kaçmaz
  • Bircan Kayaaslan
  • Nurcan Baykam
  • Alpay Arı
  • Aziz Öğütlü
  • Saygın Nayman Alpat
  • Yasemin Durdu
  • Özgür Günal
  • Yunus Gürbüz
  • Emsal Aydın
  • Selma Tosun
  • Fehmi Tabak
  • Association to Combat Viral Hepatitis-Academic Camp Group
Viral Hepat J 2014; 20: 95-100 DOI: 10.4274/vhd.98698
Interleukin 28B rs12979860 CT, rs12980275 GA, rs8099917 GT and TT genotypes are the Predictors of Rapid Viral Response in Hepatitis C Virus-Infected Patients
  • Aydin RÜSTEMOĞLU
  • Didem YALÇIN
  • Özgür GÜNAL
  • Betül ÇELİK
  • Şener BARUT
  • Ömer ATEŞ
Viral Hepat J 2016; 22: 97-102 DOI: 10.4274/vhd.51523
The Evaluation of HCV RNA, Serum Transaminases and AST/ALT Values of Anti-HCV Positive Patients
  • Tuba KAYMAN
  • Çiğdem KARAKÜKÇÜ
  • Ahmet GÖDEKMERDAN
Viral Hepat J 2013; 19: 99-102 DOI: 10.4274/Vhd.69885
The Factors Mfecting the Sustained Virological Response in Chronic Hepatitis C Treatment
  • Yunus GÜRBÜZ
  • Ediz TÜTÜNCÜ
  • Baris ÖZTÜRK
  • Ferit KUSCU
  • Irfan SENCAN
Viral Hepat J 2008; 13: 106-110
Relationships between Serum ALT Levels, Anti-HCV and HCV RNA
  • Canan KÜLAH
  • Füsun BEGENDIK CÖMERT
  • Elif AKTAS
  • Nagehan ÖZLÜ
  • Zafer MENGELOGLU
Viral Hepat J 2007; 12: 116-120
Seroprevalence of Hepatitis B and C among Patients Admitted to a Tertiary Hospital
  • Şafak Kaya
  • Birol Baysal
  • Hakan Temiz
  • Ömer Karadağ
  • Kevser Özdemir
  • Fulya Bilman
Viral Hepat J 2014; 20: 120-124 DOI: 10.4274/vhd.95967
Combination of Interferon Induction Therapy and Ribavirin in Chronic Hepatitis C Patients: Results of a Multicenter Clinical Trial
  • Bilgehan AYGEN
  • Orhan YILDIZ
  • Rahmet ÇAYLAN
  • Iftihar KÖKSAL
  • Nese SALTOGLU
  • Yesim TASOVA
  • Hakan LEBLEBICIOGLU
  • Saban ESEN
Viral Hepat J 2004; 9: 123-129
HBsAg, Anti-Hepatitis C Virus and Anti-HIV Seroprevalence Among Patients Admitted to Our Hospital between 2005 and 2013
  • Havva Avcıküçük
  • Serap Süzük
  • Mehmet Kavak
Viral Hepat J 2014; 20: 125-130 DOI: 10.4274/vhd.29190
Intrafamilial Transmission of Hepatitis C Virus
  • Fatma HANEDAN
  • Fatih KÖKSAL
  • Canan AGLAR
  • Tuna DEMIRDAL
  • Çari ERGIN
  • Yunus GÜRBÜZ
  • Rüçhan TÜRKYILMAZ
Viral Hepat J 2004; 9: 135-139
HBsAg, Anti-HBs and Anti- HCV Serologic Indicators of the Haemodialysis Unit Workers and Haemodialysis Patients, and Hand Hygiene Compliance Rates of the Workers
  • Serap SÜZÜK
  • Dilek ÖZTAŞ
  • Havva AVCIKÜÇÜK
  • Arzu ÇALIK
Viral Hepat J 2013; 19: 136-139 DOI: 10.4274/Vhd.42713
The Evaluation of Acute Viral Hepatitis Cases
  • Mustafa Kemal ÇELEN
  • Celal AYAZ
  • Salih HOSOGLU
  • Mehmet ULUG
Viral Hepat J 2004; 9: 147-151

Review

Current Treatment Approach in Acute Hepatitis C Infection
  • Rahmet GÜNER
  • Bircan KAYAASLAN
Viral Hepat J 2017; 23: 1-5 DOI: 10.4274/vhd.91886
Chronic Viral Hepatitis in Human Immunodeficiency Virus-infected Patients
  • Uluhan SİLİ
  • Aysun TEKİN
  • Volkan KORTEN
Viral Hepat J 2016; 22: 39-42 DOI: 10.4274/vhd.07279
Viral Hepatitis in Denmark
  • Işık SOMUNCU JOHANSEN
  • Nina WEIS
  • Peer BREHM CHRISTENSEN
Viral Hepat J 2014; 20: 43-48 DOI: 10.4274/vhd.02411
Viral Hepatitis in Croatia
  • Rok CIVLJAK
  • Marina KLJAKOVIC-GASPIC
  • Bernard KAIC
  • Nikola BRADARIC
Viral Hepat J 2014; 20: 49-56 DOI: 10.4274/vhd.36035
Animal Models for Hepatitis C Infection Studies
  • Ferhat Gürkan ASLAN
  • Mustafa ALTINDİŞ
Viral Hepat J 2015; 21: 65-71 DOI: 10.4274/vhd.44366
Improvement and New Aspects of HCV Testing for Clinical Management
  • Mehmet ÖZDEMİR
  • Mustafa ALTINDİŞ
Viral Hepat J 2013; 19: 93-98 DOI: 10.4274/Vhd.62634

Case Report

Elbasvir/Grazoprevir Experience - A New Glance at HCV Treatment: Case Report
  • Mustafa Kemal ÇELEN
  • İrem AKDEMİR
  • Recep TEKİN
  • Kadim BAYAN
  • Celal AYAZ
Viral Hepat J 2017; 23: 34-36 DOI: 10.4274/vhd.10337
A Case of Acute Hepatitis C in a Hemodialysis Patient
  • Nuran SARI
  • Derya Özcan KANAT
  • Dilek ARMAN
  • Firdevs AKTAŞ
  • Fatma ULUTAN
Viral Hepat J 2008; 13: 40-44
Chronic Hepatitis C Treatment-Related Skin Rash: A Report of Two Cases
  • Tuğba ARSLAN GÜLEN
  • Ayfer İMRE
Viral Hepat J 2015; 21: 59-61 DOI: 10.4274/vhd.96268
Dermatological Side Effects in a Patient with Hepatitis C Infection During Treatment with Pegylated Interferon/Ribavirin+Telaprevir: A Case Report
  • Tugba SARI
  • Suda Tekin KORUK
  • Fatih TEMOÇIN
Viral Hepat J 2014; 20: 81-84 DOI: 10.4274/vhd.38358
Nosocomial Acute Hepatitis C: Two Cases Report
  • Celal ÇALISIR
  • Süda TEKIN KORUK
  • Leman KARAAGAÇ
  • Hasan KARSEN
Viral Hepat J 2011; 17: 88-91
Partial Splenic Embolization may be an Option to Overcome Thrombocytopenia Interfering with Triple Therapy in HCV (+) Cirrhotic Patients: A Case Report
  • Mehmet ASİL
  • Murat BIYIK
  • Sami ÇİFÇİ
  • Serhat SAYIN
  • Ramazan UÇAR
  • Orhan ÖZBEK
  • Hüseyin ATASEVEN
  • Hakkı POLAT
  • Ali DEMİR
Viral Hepat J 2015; 21: 102-105 DOI: 10.4274/vhd.81300
Pegylated Interferon Alpha 2a Associated Dermatitis: A Case Report
  • Saygin NAYMAN ALPAT
  • Salih Atakan NEMLI
  • Nurettin ERBEN
  • Elif DOYUK KARTAL
  • Ilhan ÖZGÜNES
  • Gaye USLUER
Viral Hepat J 2009; 14: 116-118
Sensorineural Hearing Loss Due to Pegylated Interferon Alfa/Ribavirin Therapy: A Case Report
  • Tugba SARI
  • Süda TEKIN KORUK
  • Alaaddin ZIREK
Viral Hepat J 2012; 18: 123-125 DOI: 10.4274/Vhd.66376
Chronic Hepatitis C Treatment in a Thalassemia Major Patient: A Case Report
  • Kaya Hüseyin Süer
  • Dilara İnan
Viral Hepat J 2014; 20: 134-137 DOI: 10.4274/vhd.83803

Brief Report

HBs Ag, Anti-HBs, Anti-HBc Total and Anti-HCV Seroprevalence of the Patients Applied to Beytepe Military Hospital
  • Mehmet ÇOBAN
  • Erdim SERTOĞLU
Viral Hepat J 2013; 19: 152-155 DOI: 10.4274/Vhd.36844

Other

Induction Therapy with Interferon-Alpha 2b in Naive Chronic Hepatitis C Patients
  • Hakan LEBLEBICIOGLU
  • Mustafa SÜNBÜL
  • Bilgehan AYGEN
  • Yasemin ERSOY
  • Kemalettin AYDIN
  • Ilyas DÖKMETAS
Viral Hepat J 2003; 8: 0-0
Seroprevalence of Hepatitis B and Hepatitis C in Health Care Workers in a New Established Medical Faculty Hospital
  • Demet KAYA
  • Zeynep BAHTIYAR
Viral Hepat J 2003; 8: 0-0
THE DISTRIBUTION OF HEPATITIS C VIRUS (HCV) GENOTYPES IN PATIENTS WITH CHRONIC HEPATITIS C INFECTION
  • Ali HAFTA
  • Fügen YARKIN
Viral Hepat J 2000; 6: 0-0
DETERMINATING THE HEPATITIS B AND HEPATITIS C SEROPREVALANCE OF THE BARBERS IN KIRIKKALE CITY
  • Dilek KILIÇ
  • R. Cenap YILDIRIM
  • Teoman Z. APAN
Viral Hepat J 2000; 6: 0-0
CHRONIC HEPATIT C TREATMENT WITH INTERFERON ALPHA 2b-RIBAVIRIN COMBINATION THERAPY
  • Ismail BALIK
  • Osman MEMIKOGLU
Viral Hepat J 2001; 7: 0-0
AKUT VE KRONIK VIRAL HEPATITLI HASTALARDA LIPID PEROKSIDASYONU VE OKSIDASYONA DIRENCIN INCELENMESI
  • Birgül KAÇMAZ
  • Elmas ÖGÜS
  • Hatice PASAOGLU
  • Dilek KILIÇ
  • Necla TÜLEK
  • Fatih BAKIR
Viral Hepat J 2001; 7: 0-0
SEROPREVALANCE OF HBsAg, ANTI-HBs AND ANTI-HCV IN SANLIURFA
  • Gönül ASLAN
  • Mustafa ULUKANLIGIL
  • Adnan SEYREK
Viral Hepat J 2001; 7: 0-0
INCIDENCE OF HEPATITIS B, HEPATITIS C, AND HIV INFECTIONS IN BLOOD-DONORS, SOLDIERS AND HEALTHY POPULATION IN NORTHERN CYPRUS
  • Mustafa ALTINDIS
  • Sebahattin YILMAZ
  • Tansel DIKENGIL
Viral Hepat J 2001; 7: 0-0
Comparasion of a commercial assay (Amplicor HCV) with nested PCR in the diagnosis of hepatitis C virus infection
  • Salih TÜRKOGLU
  • Mürvet BOZACI
  • Banu Bayraktar
  • Ayfer Ataysaggin
  • Selim BADUR
Viral Hepat J 1996; 1: 0-0
Plasma Zinc and Copper Levels in Chronic Viral Hepatitis Cases
  • Fatma SIRMATEL
  • Iclal GEYIKLI
  • Sibel AHI
  • Mehmet TARAKÇIOGLU
Viral Hepat J 2003; 8: 0-0
Seroprevalence of Hepatitis B and Hepatitis C Infections in Ankara City
  • Birgül KAÇMAZ
Viral Hepat J 2003; 8: 0-0
Seroprevalence of HBV and HCV in Patients with Chronic Disease
  • Irfan SENCAN
  • Idris SAHIN
  • Yasar SERTBAS
  • Öner BALBAY
  • Ismet BULUT
Viral Hepat J 2003; 8: 0-0
The Evaluation of Three Years Results of HBV and HCV Serological Markers in Our Hospital
  • Mehmet ÖZDEN
  • Kutbettin DEMIRDAG
  • Ahmet KALKAN
Viral Hepat J 2003; 8: 0-0
The Case of Nosocomial Acute Hepatitis C
  • Nese DEMIRTÜRK
Viral Hepat J 2003; 8: 0-0
Seroprevalence of Viral Hepatitis A, B, C in the High Risk Group of Health Workers
  • Sükran KÖSE
  • Aydan SARICA
  • Figen ÇAGLAN ÇEVIK
  • Mete CÜCE
Viral Hepat J 2003; 8: 0-0
Evaluation of Antiviral Treatment in Chronic Hepatitis C Infection
  • Mehmet AKKUS
  • Mustafa SÜNBÜL
  • Saban ESEN
  • Cafer EROGLU
  • Hakan LEBLEBICIOGLU
Viral Hepat J 2004; 9: 12-17
Long-Term Follow-Up of Hepatitis C Patients with Virological and Biochemical Response to Therapy and Investigation of Factors Predicting Relapses
  • Bahadir CEYLAN
  • Muzaffer FINCANCI
  • Cüneyt MUDERRISOGLU
  • Ferda SOYSAL
  • Gülhan EREN
Viral Hepat J 2007; 12: 14-23
Assessment of Risk Factors Related to Transmission of Hepatitis C in Patients with Chronic Hepatitis C and Their Family
  • Hasan UÇMAK
  • Mustafa ÇELIK
  • Ömer Faruk KÖKOGLU
  • Nuretdin KUZHAN
  • Remzi TOPRAK
  • Ekrem GÜLER
  • Mehmet DAVUTOGLU
Viral Hepat J 2007; 12: 24-29
Evaluation of Life Qality in Patients with Hepatitis C
  • Ismet ESER
  • Leyla KHORSHID
  • Gülengün TÜRK
Viral Hepat J 2006; 11: 41-45
Prevalance of HBsAg, Anti-HBs, Anti-HBc Total, Anti-HBc IgM, Anti-HCV andAnti-HAV IgG in Hemodialysis Patients
  • Ayten KADANALI
  • Suna PIRIMOGLU
  • Kemalettin ÖZDEN
Viral Hepat J 2004; 9: 41-45
HBsAg, Anti-HCV and Anti-HIV Seropositivity in Women Aged Between 18 and 45 Years
  • Mehmet S. TEKEREKOGLU
  • Elif AKTAS
  • Ibrahim H. ÖZEROL
  • Riza DURMAZ
Viral Hepat J 2004; 9: 46-49
ombined Therapy of Acute Hepatitis C in a Health Care Worker: A Case Report
  • Günay TUNCER ERTEM
  • Necla TÜLEK
  • Behiç ORAL
  • Sami KINIKLI
Viral Hepat J 2004; 9: 53-55
Treatment of Chronic Hepatitis C with Alpha Interferon in Hemodialysis Patients
  • Fatih BESISIK
  • Salih TÜRKOGLU
  • Sabahattin KAYMAKOGLU
  • Mürvet BOGAZCI
  • Levent ERDEM
  • Mehmet SEVER
  • Alaattin YILDIZ
  • Selim GÜREL
  • Yilmaz ÇAKALOGLU
  • Atilla ÖKTEN
  • Selim BADUR
Viral Hepat J 1995; 1: 57-60
Evaluation of 230 Acute Viral Hepatitis Cases Hospitalized in Izmir Atatür State Hospital, Clinic of Infectious Disease Between 1993-1996
  • Nükhet KURULTAY
  • Serap SURAL
  • Nejat Ali COSKUN
  • Metin TÜRKER
  • Figen KAPTAN
  • Gamze GÜLFIDAN
Viral Hepat J 1996; 2: 66-69
Evaluation of Thyroid Functions During Interferon-Alpha Treatment ofPatients with Chronic Viral Hepatitis
  • Mustafa SÜNBÜL
  • Ertan SAHBAT
  • Mehmet AKKUS
  • Saban ESEN
  • Hakki KAHRAMAN
  • Hakan LEBLEBICIOGLU
Viral Hepat J 2004; 9: 67-71
Intrafamillial Transmission of Hepatitis C Virus Infection
  • Aysegül H. ÖZAKYOL
  • Hasan YAVUZ
  • Tülay SARIÇAM
  • Eser VARDARELI
  • Zafer GÜLBAS
  • Esat ERENOGLU
Viral Hepat J 1999; 5: 69-71
Kronik akci¤er hastal›¤›, hepatit B viru¨su¨, hepatit C viru¨su¨, nozokomiyal geçifl.
  • Sener BARUT
  • Serpil ÖCAL
  • Ayse YILMAZ
  • Handan INÖNÜ
  • Ünal ERKORKMAZ
  • Özcan AVCI
Viral Hepat J 2006; 11: 70-75
Interferon Alpha 2b Therapy in Acute Viral Hepatitis C:Two Years Followed Up of Seven Case
  • Funda SIMSEK
  • Fatma YÜKSEL
  • Lütfü SAVAS
Viral Hepat J 2004; 9: 72-75
Hepatitis C Virus Infection Incidences in Patients with Chronic Obstructive Pulmonary Disease
  • Mustafa ALTINDIS
  • Ayse ORMAN
  • Mehmet ÜNLÜ
  • Yücel KIRLANGIÇ
Viral Hepat J 2004; 9: 76-81
Seroprevalences of Hepatitis A, B, C and Hepatitis B Vaccination in Health Care Workers in Mersin University Faculty of Medicine
  • Gülden ERSÖZ
  • Elif SAHIN
  • Özlem KANDEMIR
  • Öner KURT
  • Nuran DELIALIOGLU
  • Ali KAYA
  • Gürol EMEKDAS
Viral Hepat J 2006; 11: 84-88
Impact of Exposure to Hepatitis B Virus in Blood Donors on the Incidence of Posttransfusional Hepatitis C
  • Ayse Gül MUTLU
  • Muzaffer FINCANCI
  • Özcan NAZLICAN
  • Birsen MUTLU
Viral Hepat J 1995; 1: 84-86
The Seroprevalence of Hepatitis C virus (HCV) in HIV infected Patients and Blood Donors
  • Muzaffer FINCANCI
  • Ayse Gül MUTLU
  • Özcan NAZLICAN
  • Dilek MAMÇU
Viral Hepat J 1995; 1: 94-96
A Case of Erythema Multiforme Related to Pegylated Interferon-a2a Plus Ribavirin Treatment for Chronic Hepatitis C Virus Infection
  • Ilhan ÖZGÜNES
  • Elif DOYUK KARTAL
  • Nurettin ERBEN
  • Saygin NAYMAN ALPAT
  • Gaye USLUER
Viral Hepat J 2006; 11: 101-104
Does Hepatitis C Cause Polyarthristis 'A Report of Two Case'
  • Iftihar KÖKSAL
  • Kemalettin AYDIN
  • Mehmet TOSUN
  • Rahmet ÇAYLAN
  • Serkan VOLKAN
Viral Hepat J 1997; 3: 106-108
The Investigation of HBsAg and Anti-HCV Seroprevalence in Cleaning Staff and Nurse in a University Hospital
  • Nuran SARI
  • Özgür GÜNAL
  • Murat DIZBAY
  • Kenan HIZEL
  • Firdevs AKTAS
Viral Hepat J 2006; 11: 126-131
Comparison of the Effect of Standard IFN-a Treatment and Standard IFN-a plus Ribavirin Therapy in Patients with Naive Chronic Hepatitis C
  • Nail ÖZGÜNES
  • Fatma SARGIN
  • Saadet YAZICI
  • Ayse Canan ÜÇISIK
  • Nüket CEYLAN
  • Pinar ERGEN
  • Özlem AYDIN
  • Arzu DOGRU
Viral Hepat J 2005; 10: 135-138
The Relationship of Hepatitis C Seroprevalence and Age, Sex, and Hemodialysis Time of Patients Undergoing Hemodialysis
  • Muhammet Güzel KURTOGLU
  • Hamza BOZKURT
  • Recep KESLI
  • Mustafa BERKTAS
Viral Hepat J 2006; 11: 142-147
Seroprevalences of Hepatitis B and C Among Dentists and Other Dental Health Care Workers in Kahraman Maras City
  • Hasan UÇMAK
  • Ömer Faruk KÖKOGLU
  • Mustafa ÇELIK
  • Nuretdin KUZHAN
  • Remzi TOPRAK
Viral Hepat J 2006; 11: 148-152
The Frequency of Hepatitis B, Hepatitis C and Hepatitis G Virus in Patients with Beta-Thalassemia Major Who Receive Frequent Blood Transfusion
  • Cihat Sanli
  • Meryem ALBAYRAK
  • Fikret NAKIPOGLU
  • Fatma GÜMRÜK
Viral Hepat J 2005; 10: 150-157
Seroprevalence of Anti-HAV, HBsAg, Anti-HBs and Anti-HCV According to Age and Sex in K›r›kkale
  • Sedat KAYGUSUZ
  • Dilek KILIÇ
  • Ergin AYASLIOGLU
  • Özlem ÖZLÜK
  • Levent CERIT
  • Aysenur YILDIRIM
Viral Hepat J 2003; 8: 160-165
Hepatit C Virus Seroprevalence Central and Rural Areas of Erzurum
  • Servet KÖLGELIER
  • Mustafa ERTEK
  • Serpil EROL
  • Mehmet A. TASYARAN
Viral Hepat J 2003; 8: 166-170
The Hepatitis B and Hepatitis C Seroprevalence of Blood Donors
  • Tuba TURUÇ
  • Nurzen SEZGIN
  • Hikmet UNCU
  • Y.Ziya DEMIROGLU
  • Hande ARSLAN
Viral Hepat J 2003; 8: 171-173
IS HCV INFECTION AN ADDITIONAL RISK FACTOR FOR DEVELOPMENT OF TYPE-2 DIABETES
  • O. ÖNCÜL
  • C. TOP
  • S. ÇAVUSLU
Viral Hepat J 2002; 8: 436-440
THE EVALUATION OF INTRAERYTHROCYTE SUPEROXIDE DISMUTASE AND CATALASE ACTIVITY IN THE PATIENTS WITH HEPATITIS C INFECTION
  • Aysun BAY KARABULUT
  • Yasar BAYINDIR
  • Çetin ÖZTÜRK
  • Emine SÖNMEZ
  • Kadir BATICIOGLU
  • Engin GÖZÜKARA
Viral Hepat J 2002; 8: 447-450
THE SEROPREVALENCE OF HEPATITIS A, BAND C IN CHILDREN LIVING IN SANLIURFA CITY
  • C.Dost ZEYREK
  • Fadile YILDIZ ZEYREK
  • Akin ISCAN
  • Eylem SEVINÇ
Viral Hepat J 2002; 8: 467-470
LIPID PEROXIDATION IN HEPATIT C INFECTION
  • Süleyman DEMIR
  • Ilknur KALELI
  • Diler ASLAN
  • Özlem YURTSEVEN
Viral Hepat J 2002; 8: 538-539
PREVALENCE OF HEPATITIS G VIRUS INFECTION AMONG PATIENTS WITH CHRONIC HEPATITIS C
  • Ali HAFTA
  • Fügen YARKIN
Viral Hepat J 2002; 8: 542-545

About Journal

Forms

Useful Links

Applications